Your browser doesn't support javascript.
loading
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.
Bafadhel, Mona; Rabe, Klaus F; Martinez, Fernando J; Singh, Dave; Darken, Patrick; Jenkins, Martin; Aurivillius, Magnus; Patel, Mehul; Dorinsky, Paul.
Afiliação
  • Bafadhel M; Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Rabe KF; LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Martinez FJ; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Hospitals Trust, Manchester, UK.
  • Darken P; AstraZeneca, Gaithersburg, MD, USA.
  • Jenkins M; AstraZeneca, Cambridge, UK.
  • Aurivillius M; AstraZeneca, Gothenburg, Sweden.
  • Patel M; AstraZeneca, Cambridge, UK.
  • Dorinsky P; Formerly of AstraZeneca, Durham, NC, USA.
Int J Chron Obstruct Pulmon Dis ; 17: 3061-3073, 2022.
Article em En | MEDLINE | ID: mdl-36510486
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Glicopirrolato Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Glicopirrolato Idioma: En Ano de publicação: 2022 Tipo de documento: Article